Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Patent
1992-07-24
2000-06-27
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
514679, 514680, 514681, 514682, 514728, 514732, 514734, 514736, A61K 3112, A61K 31045, A61K 3105
Patent
active
060807911
ABSTRACT:
A method of preventing and treating a viral condition caused by an enveloped virus is described, comprising using a therapeutically effective amount of a compound selected from the group consisting of a substituted hydroquinone and the corresponding benzoquinone, wherein said hydroquinone comprises a 2-R.sup.1, 3-R.sup.2 -1,4-hydroquinone where at least one of R.sup.1 and R.sup.2 include a carbon linkage to the benzene ring of the hydroquinone. Particularly useful compounds include 5,8-dihydro-5,8-methano-1,4-naphthalenediol, 1,4-naphthoquinone, 3', 6'-dihydroxybenzo-norbornane, tert-butylhydroquinone, other diols, e.g. 1,5-naphthalenediol, and alkylated diols, e.g. 4-methoxy-1-naphthol.
REFERENCES:
patent: 4898891 (1990-02-01), Lavic et al.
Bogdonova et al 73 CA 129328z 1970.
Thiel et al 84 CA 160055 1996.
Korsakova et al 96 CA:199209k 1982.
Lyubehanskaga et al 115 CA 231795x 1991.
Griueu et al 85 CA: 56546 c 1976.
Connolly, M. L., "Solvent-accessible surfaces of proteins and nucleic acids." Science 221: 709-13 (1983).
Doms, R. W., Gething, M.-J., Henneberry, J., White, J. and Helenius, A., "Variant influenza virus hemagglutinin that induces fusion at elevated pH." J. Virol. 57: 603-13 (1986).
Doms, R. W., Helenius, A. and White, J., "Membrane fusion activity of the influenza virus hemagglutinin the low pH-induced conformational change." J. Biol. Chem. 260: 2973-81 (1985).
Ferrin, T. E., Huang, C. C., Jarvis, L. E. and Langridge, R., "The Midas display system." J. Mol. Graph. 6: 13-27 (1988).
Gasteiger, J. and Marsili, M., "Iterative partial equalization of orbital electronegativity--a rapid access to atomic charges." Tetrahedron 36: 3219-88 (1980).
Goodman & Gilman, The Pharmacological Basis of Therapeutics, 7th Edition, MacMillan, (1985) at p. 1232.
Abola, E.E., Berstein, F.C., Bryant, S.H., Koetzle, T.F. and Weng, J., in F. H. Allen, G. Bergerhoff and R. Seivers (Eds.), Crystallographic Databases-Information Content, Software Systems, Scientific Applications, (Data Commission of the International Union of Crystallography, Cambridge, 1987) pp. 107-32.
Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R. and Ferrin, T. E., "A geometric approach to macromolecule-ligand interactions." J. Mol. Biol. 161: 269-88 (1982).
M. Kielian and S. Jungerwirth, "Mechanisms of Enveloped Virus Entry into Cells," Mol. Biol. Med. 7: 17-31 (1990).
Mosmann, T., "Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays." J. Immunol. Methods 65: 55-63 (1983).
Porter, R. F., Rees, W. W., Frauenglass, E., Wilgus, H. S., Nawn, G. H., Chiesa, P. P. and Gates, J. W., "The chemistry of thioether-substituted hydroquinones and quinones. I. The 1,4 addition of a heterocyclic mercaptan to quinones," J. Org. Cem. 29: 588-94 (1964).
Still, W.C., Kahn, M. and Mitra, A., "Rapid chromatographic technique for preparative separations with moderate resolution," J. Org. Chem. 43: 2923-25 (1978).
Shoichet, B. K., Bodian, D. L. and Kuntz, I. D., "Molecular docking using shape descriptors." J. Comp. Chem. 13: 380-97 (1992).
Simons, K., Garoff, H. and Helenius, A., "How an animal virus gets into and out of its host cell," Sci. Am. 246: 58-66 (1982).
Skehel, J. J. and Schild, G. C., "The polypeptide composition of influenza A viruses," Virology 44: 396-408 (1971).
Stegmann, T., Delfino, J. M., Richards, F. M. and Helenius, A., "The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion," J. Biol. Chem. 266: 18404-10 (1991).
White, J. M. and Wilson, I. A., "Anti-peptide antibodies detect steps in a protein conformational change low pH activation of the influenza virus hemagglutinin." J. Cell Bio. 105: 2887-96 (1987).
White, J. M., "Viral and cellular membrane fusion proteins," Ann. Rev. Physiol. 52: 675-97 (1990).
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Jr., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., et al., "The Protein Data Bank: A computer-based archival file for macromolecular structures," J. Mol. Biol. 112: 535-42 (1977).
Wilson, I. A., Skehel, J. J. and Wiley, D. C., "Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3 .ANG. resolution," Nature 289: 366-73 (1981).
Bodian Dale L.
Kuntz Irwin D.
Stearns Jay F.
White Judith M.
Yamasaki R. Bryan
Cintins Marianne M.
Koenig Nathan P.
Seres Laboratories, Inc.
University of California
LandOfFree
Method of treating a viral condition by inhibiting membrane fusi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating a viral condition by inhibiting membrane fusi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating a viral condition by inhibiting membrane fusi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1785214